Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand*1 for the Third Consecutive Year Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand*1 for the Third Consecutive Year
Based on research by Euromonitor International (UK),*2 a leading global market research company TOKYO, JAPAN – Media OutReach – 17 May 2019 – Hisamitsu... Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand*1 for the Third Consecutive Year

Based on research by Euromonitor International (UK),*2 a leading global market research company

TOKYO,
JAPAN –
Media OutReach – 17 May 2019 – Hisamitsu Pharmaceutical Co., Inc. (Head
Office: Tosu, Saga; President & COO: NAKATOMI Kazuhide; hereinafter
“Hisamitsu Pharmaceutical”) announced that Euromonitor International Ltd.
(hereinafter “Euromonitor International”), a leading international market
research company, recognized “Salonpas®” as the world’s No. 1 OTC
topical analgesic patch brand for the third consecutive year since 2016.
Euromonitor International presented Hisamitsu Pharmaceutical with two official
certificates, one recognizing Salonpas®‘s achievement and one naming
Hisamitsu Pharmaceutical as the holder of the world’s largest share in the
corresponding market category for two years running.


Since its 1847 founding in the Tashiro (then
Hizen-Tashiro) area of Tosu, Saga, Hisamitsu Pharmaceutical has worked to provide
Japan and the rest of the world with high-quality pharmaceutical products. Always
footing its operations in that local foundation and adhering to a consistent, customer-first
philosophy, Hisamitsu Pharmaceutical is now in its 172nd year–a testament to a legacy
that, like the recent recognition from Euromonitor International, would not
have been possible without the valuable, ongoing support of the company’s many customers
and stakeholders.


May 18 has been registered with the Japan
Anniversary Association as “Salonpas® Day,” whose date has
linguistic ties to the Japanese phrase “Kori
o iyasu
” (“relieving stiffness”): “Ko
corresponds to the number 5 (“go“); “i” represents 1; and “ya” stands for 8.


Hisamitsu Pharmaceutical will continue to
expand its business operations worldwide, centering its activities on the basic
principle of “Delivering a Better QOL to the World.”

Certificate
presentation

Date: May
17, 2019

Location: Hisamitsu Pharmaceutical Tokyo Head
Office

L: Mr. Sean Kreidler, Senior
Research Manager, Euromonitor International

R: NAKATOMI Kazuhide,
President & COO, Hisamitsu Pharmaceutical

*1: Research Method

To determine the
world’s No. 1 OTC topical analgesic patch brand, London-based Euromonitor
International conducts a global market research from March to April every year.
In the ten countries collectively representing more than 70% of the global
topical patch product retail market in 2018 (the United States, Brazil, Russia,
Italy, Germany, India, Indonesia, Vietnam, China, and Japan), Euromonitor
International conducted trade interviews of manufacturers and wholesalers,
visited retail outlets for store checks, and compiled the sales figures of
patch products by country and brand to calculate the corresponding sales
shares.

*2: Euromonitor
International

Euromonitor International,
a British company headquartered in London, is a leader in international market
research with exclusive researchers in over 100 countries.

Source:: Media Outreach

admin